620 related articles for article (PubMed ID: 22955364)
41. Probiotics for the treatment of women with bacterial vaginosis.
Falagas M; Betsi GI; Athanasiou S
Clin Microbiol Infect; 2007 Jul; 13(7):657-64. PubMed ID: 17633390
[TBL] [Abstract][Full Text] [Related]
42. A New Phenotype in
Sala A; Ardizzoni A; Spaggiari L; Vaidya N; van der Schaaf J; Rizzato C; Cermelli C; Mogavero S; Krüger T; Himmel M; Kniemeyer O; Brakhage AA; King BL; Lupetti A; Comar M; de Seta F; Tavanti A; Blasi E; Wheeler RT; Pericolini E
mBio; 2023 Apr; 14(2):e0010723. PubMed ID: 36856418
[TBL] [Abstract][Full Text] [Related]
43. Anti-Candida activity of beneficial vaginal lactobacilli in in vitro assays and in a murine experimental model.
De Gregorio PR; Silva JA; Marchesi A; Nader-Macías MEF
FEMS Yeast Res; 2019 Mar; 19(2):. PubMed ID: 30689833
[TBL] [Abstract][Full Text] [Related]
44. Anti-inflammatory effect of two Lactobacillus strains during infection with Gardnerella vaginalis and Candida albicans in a HeLa cell culture model.
Santos CMA; Pires MCV; Leão TL; Silva AKS; Miranda LS; Martins FS; Silva AM; Nicoli JR
Microbiology (Reading); 2018 Mar; 164(3):349-358. PubMed ID: 29458690
[TBL] [Abstract][Full Text] [Related]
45. Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis.
Ehrström S; Daroczy K; Rylander E; Samuelsson C; Johannesson U; Anzén B; Påhlson C
Microbes Infect; 2010 Sep; 12(10):691-9. PubMed ID: 20472091
[TBL] [Abstract][Full Text] [Related]
46. An evaluation of risk factors in pregnant women with Candida vaginitis and the diagnostic value of simultaneous vaginal and rectal sampling.
Guzel AB; Ilkit M; Burgut R; Urunsak IF; Ozgunen FT
Mycopathologia; 2011 Jul; 172(1):25-36. PubMed ID: 21293929
[TBL] [Abstract][Full Text] [Related]
47. Mycobiome Study Reveals Different Pathogens of Vulvovaginal Candidiasis Shape Characteristic Vaginal Bacteriome.
Zhao C; Li Y; Chen B; Yue K; Su Z; Xu J; Xue W; Zhao G; Zhang L
Microbiol Spectr; 2023 Jun; 11(3):e0315222. PubMed ID: 36995230
[TBL] [Abstract][Full Text] [Related]
48. Changing virulence factors among vaginal non-
Kalaiarasan K; Singh R; Chaturvedula L
Indian J Med Microbiol; 2018; 36(3):364-368. PubMed ID: 30429388
[TBL] [Abstract][Full Text] [Related]
49. Development of probiotic loaded multilayer microcapsules incorporated into dissolving microneedles for potential improvement treatment of vulvovaginal candidiasis: A proof of concept study.
Kristina Enggi C; Sulistiawati S; Stephanie S; Tangdilintin F; Anas Achmad A; Adelia Putri R; Burhanuddin H; Arjuna A; Manggau MA; Dian Permana A
J Colloid Interface Sci; 2023 Oct; 648():203-219. PubMed ID: 37301145
[TBL] [Abstract][Full Text] [Related]
50. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis.
Maraki S; Mavromanolaki VE; Stafylaki D; Nioti E; Hamilos G; Kasimati A
Mycoses; 2019 Aug; 62(8):692-697. PubMed ID: 31132175
[TBL] [Abstract][Full Text] [Related]
51. Does vaginal douching affect the type of candidal vulvovaginal infection?
Shaaban OM; Abbas AM; Moharram AM; Farhan MM; Hassanen IH
Med Mycol; 2015 Nov; 53(8):817-27. PubMed ID: 26129887
[TBL] [Abstract][Full Text] [Related]
52. Inhibitory effects of Lactobacillus casei Shirota against both Candida auris and Candida spp. isolates that cause vulvovaginal candidiasis and are resistant to antifungals.
Paniágua AL; Correia AF; Pereira LC; de Alencar BM; Silva FBA; Almeida RM; de Medeiros Nóbrega YK
BMC Complement Med Ther; 2021 Sep; 21(1):237. PubMed ID: 34556109
[TBL] [Abstract][Full Text] [Related]
53. Comparative Analysis of the Capacity of the
Willems HME; Lowes DJ; Barker KS; Palmer GE; Peters BM
Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30249743
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
55. Randomised clinical trial in women with Recurrent Vulvovaginal Candidiasis: Efficacy of probiotics and lactoferrin as maintenance treatment.
Russo R; Superti F; Karadja E; De Seta F
Mycoses; 2019 Apr; 62(4):328-335. PubMed ID: 30565745
[TBL] [Abstract][Full Text] [Related]
56. Isolation of Vaginal Lactobacilli and Characterization of Anti-Candida Activity.
Parolin C; Marangoni A; Laghi L; Foschi C; Ñahui Palomino RA; Calonghi N; Cevenini R; Vitali B
PLoS One; 2015; 10(6):e0131220. PubMed ID: 26098675
[TBL] [Abstract][Full Text] [Related]
57. Vaginal lactobacilli inhibit growth and hyphae formation of Candida albicans.
Jang SJ; Lee K; Kwon B; You HJ; Ko G
Sci Rep; 2019 May; 9(1):8121. PubMed ID: 31148560
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species.
Guzel AB; Ilkit M; Akar T; Burgut R; Demir SC
Med Mycol; 2011 Jan; 49(1):16-25. PubMed ID: 20608776
[TBL] [Abstract][Full Text] [Related]
59. Epidemiology, risk factors and antimicrobial profile of Vulvovaginal Candidiasis (VVC): A study among women in the central region of Saudi Arabia.
Venugopal D; Husain K; Mustafa SA; Sabeen S
J Mycol Med; 2021 Jun; 31(2):101049. PubMed ID: 33153879
[TBL] [Abstract][Full Text] [Related]
60. Prevalence and species distribution of microorganisms isolated among non-pregnant women affected by vulvovaginal candidiasis: A retrospective study over a 20 year-period.
Intra J; Sala MR; Brambilla P; Carcione D; Leoni V
J Mycol Med; 2022 Aug; 32(3):101278. PubMed ID: 35523109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
